Moreover, El-Khazragy and colleagues showed that HOTAIR may be a biological marker to predict the risk of developing HCC following DAAs (direct-acting antivirals) in HCV-related cirrhosis, allowing for the selection of patients at higher risk of developing HCC after DAAs treatment [165]. This evidence concerns the gene HOTAIR and Cirrhosis.